Sudan | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2018
The value of exports of commodity group 30 "Pharmaceutical products" from Sudan totalled $ 1.05 million in 2018. Sales of commodity group 30 from Sudan went up by 108% compared to 2017: exports of commodity group 30 "Pharmaceutical products" went up by $ 551 thousand (cumulative exports of commodity group 30 from Sudan amounted $507 thousand in 2017)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.029% of total exports from Sudan (cumulative merchandise exports from Sudan totalled $ 3.61 billion in 2018). The share of commodity group 30 in total exports from Sudan increased by 0.017 p.p. compared to 2017 (it was 0.011% in 2017 and cumulative exports from Sudan were equal to $ 4.24 billion).
Where does Sudan export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Sudan in 2018:
- Ethiopia with a share of 65% (698 thousand US$)
- Germany with a share of 31% (331 thousand US$)
- Chad with a share of 2.31% (24 thousand US$)
- Egypt - 3.6 thousand US$
- Uganda - 944 US$
- France - 2 US$
- United Kingdom - 2 US$
- Eritrea - 1 US$
- Ireland - 1 US$
- Netherlands - 1 US$
Exports structure of 30 - Pharmaceutical products - from Sudan in 2018 represented by the following main commodity groups:
- 66% (699 thousand US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 31% (331 thousand US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 2.31% (24 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.341% (3.61 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0% (9 US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 0% (1 US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
The value of imports of commodity group 30 "Pharmaceutical products" to Sudan totalled $ 406 million in 2018. Sales of commodity group 30 to Sudan decreased by 19.8% in value terms compared to 2017. imports of commodity group 30 "Pharmaceutical products" decreased by $ 101 million (the value of imports of commodity group 30 to Sudan was equal to $508 million in 2017)
Imports of commodity group 30 "Pharmaceutical products" accounted for 3.88% of total import flow to Sudan (in 2018, total imports to Sudan amounted to $ 10.4 billion). The share of commodity group 30 in total imports to Sudan decreased by 1.06 p.p. compared to 2017 (it was 4.94% in 2017 and cumulative imports to Sudan were equal to $ 10.2 billion).
Where does Sudan import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Sudan in 2018:
- Jordan with a share of 14.4% (58 million US$)
- India with a share of 12% (49 million US$)
- Germany with a share of 9.59% (39 million US$)
- Switzerland with a share of 8.47% (34 million US$)
- Saudi Arabia with a share of 8.19% (33 million US$)
- Egypt with a share of 5.34% (21 million US$)
- China with a share of 4.98% (20 million US$)
- France with a share of 4.44% (18 million US$)
- Pakistan with a share of 4.41% (17.9 million US$)
- Denmark with a share of 3.73% (15.1 million US$)
Imports structure of 30 - Pharmaceutical products - to Sudan in 2018 represented by the following main commodity groups:
- 44% (180 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 41% (168 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 12.6% (51 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 1.11% (4.54 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.509% (2.07 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0% (3.75 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
